Zydus Lifesciences Limited (ZYDUSLIFE) announces positive topline results from completed EVIDENCES-X Phase II(b) clinical trial for Saroglitazar Mg in MASH.
Zydus Lifesciences Limited (ZYDUSLIFE) gets approval for Phase III trial of Desidustat for sickle cell disease patients.
Glenmark Pharmaceuticals Limited (GLENMARK) advances its multi-country Phase 3 clinical trial for Trastuzumab rezetecan in platinum-resistant ovarian cancer.
Suven Life Sciences Limited (SUVEN) shares positive topline results from Phase-2b trial of Ropanicant for Major Depressive Disorder.
Suven Life Sciences Limited (SUVEN) announces positive DSMB safety review and interim analysis from ongoing global Phase 3 study of Masupirdine in Alzheimer'.
Lupin Limited (LUPIN) shares positive Phase 1 data on LNP8701, a novel SOS1 inhibitor, accepted for ASCO Annual Meeting 2026.
Sun Pharma to present long-term follow-up data on UNLOXCYT™ at ASCO 2026, showing nearly 27% complete response rate.
Suven Life Sciences Limited reaches 76% enrollment in its Global Phase 3 Masupirdine trial for Alzheimer’s agitation.